Neurolief, a medical technology company developing neuromodulation therapies for mental health conditions, today announced a $6 million milestone-based investment from BrainsWay Ltd., following FDA ...

Hesheng Liu, founder and Chief Scientific Officer of Galaxy Brain Scientific Inc., has published a study in Nature Neuroscience demonstrating that Deep Brain Stimulation (DBS) achieves therapeutic ...

Electrical transcutaneous neuromodulation (eTNM) of the peroneal nerve led to fewer side effects compared with solifenacin (Vesicare) in the treatment of overactive bladder, a randomized trial showed.

Inspire Medical announced today that it received expanded FDA approval for its Inspire IV and V neuromodulation systems.

The Louisiana-based company offers its Ellipse Spinal Cord Stimulator Platform for treating chronic pain. The platform includes the company's patented and FDA-cleared StimuLux technology, which uses ...

Cognito Therapeutics announced today that it entered into a collaboration with Ochsner Health to advance new approaches to ...

Please provide your email address to receive an email when new articles are posted on . Artificial tears have long been the first option for patients with dry eye disease, but they only offer a ...

Please provide your email address to receive an email when new articles are posted on . Migraine pain relief was reported in more than 75% of users over 3 years. Treatment intensity increased by a ...

The function of the lower urinary tract — to store and periodically eliminate urine — seems simple, but its neuronal control is complex and not fully understood, and dysfunction is common. Functional ...

Lewes, Delaware, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The Global Neuromodulation Market Size is projected to grow at a CAGR of 9.27% from 2026 to 2032, according to a new report published by Verified ...